FindTrial
Sign In

The analysis of SMC4 as the primary liver cancer tumor marker and the treatment targets

The analysis of SMC4 as the primary liver cancer tumor marker and the treatment targets

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-11001845
Enrollment
Unknown
Registered
2011-12-29
Start date
2009-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary liver carcinoma

Interventions

Gold Standard:
Index test:

Sponsors

Daping Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
26 Years to 74 Years

Inclusion criteria

Inclusion criteria: All the specimens collected in this study are all primary liver cancer patients, and the patients do not receive the radiotherapy and chemotherapy or any other treatment, pathological results are confirmed after operation.

Exclusion criteria

Exclusion criteria: 1. The patient who receiveed the radiotherapy or chemotherapy; 2. The patient with serious diseases ,systemic organ failure or suffer from other tumors; 3. The patient have a history of drug abuse, or suffer from familial genetic diseases, infectious diseases, and other disease that has a little influence on the experimental results.

Design outcomes

Primary

MeasureTime frame
SMC4;—

Countries

China

Contacts

Public ContactPing Chen
chenping@263.net+86 13708349071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026